STOCK RESEARCH
Independent equity research, built for decisive investors.
Read the latest stock research notes, valuation work, and portfolio-level analysis from Muffett Investments. Uploaded PDF reports will appear on each research detail page.
PDF library workflow
Upload each report PDF to the StockResearch CMS item using the Research PDF field. The detail page button will point to that uploaded file.
Equity Analysis
Atlassian Corporation: Enterprise Collaboration at a Generational Discount
TEAM is trading significantly below peak valuations as the market reprices high-multiple SaaS. We initiate with a half position — the cloud migration cycle is mid-innings and Atlassian Intelligence adds a structural AI growth vector.
Open research note
Biotechnology / RNA Therapeutics
The RNA Interference Revolution — Alnylam Pharmaceuticals and the Future of Medicine
Alnylam has moved RNA interference from scientific discovery to a commercially validated therapeutic platform. The investment question is now whether AMVUTTRA, Leqvio economics and a widening cardiometabolic pipeline can convert that platform into a diversified, enduring and highly profitable pharmaceutical company.
Open research note